These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 23485176)
1. Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcɛRI. Sabban S; Ye H; Helm B Vet Immunol Immunopathol; 2013 May; 153(1-2):10-6. PubMed ID: 23485176 [TBL] [Abstract][Full Text] [Related]
2. Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI. Sabban S; Ye H; Helm B J Vis Exp; 2014 Nov; (93):e52222. PubMed ID: 25406512 [TBL] [Abstract][Full Text] [Related]
3. Review: Diagnostic and therapeutic applications of rat basophilic leukemia cells. Rashid A; Sadroddiny E; Ye HT; Vratimos A; Sabban S; Carey E; Helm B Mol Immunol; 2012 Oct; 52(3-4):224-8. PubMed ID: 22750069 [TBL] [Abstract][Full Text] [Related]
4. Identification of amino acid residues involved in the interaction of canine IgE with canine and human FcεRIα. Ye H; Housden JE; Hunter M; Sabban S; Helm BA Mol Immunol; 2014 Feb; 57(2):111-8. PubMed ID: 24084098 [TBL] [Abstract][Full Text] [Related]
5. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors. Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669 [TBL] [Abstract][Full Text] [Related]
6. Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity. Rudman SM; Josephs DH; Cambrook H; Karagiannis P; Gilbert AE; Dodev T; Hunt J; Koers A; Montes A; Taams L; Canevari S; Figini M; Blower PJ; Beavil AJ; Nicodemus CF; Corrigan C; Kaye SB; Nestle FO; Gould HJ; Spicer JF; Karagiannis SN Clin Exp Allergy; 2011 Oct; 41(10):1400-13. PubMed ID: 21569129 [TBL] [Abstract][Full Text] [Related]
7. Generation of canine-human Fc IgE chimeric antibodies for the determination of the canine IgE domain of interaction with Fc epsilon RI alpha. Hunter MJ; Vratimos AP; Housden JE; Helm BA Mol Immunol; 2008 Apr; 45(8):2262-8. PubMed ID: 18187193 [TBL] [Abstract][Full Text] [Related]
8. Assessing the role of Asp 194 in the transmembrane domains of the α-chain of the high-affinity receptor complex for immunoglobulin E in signal transduction. Rashid A; Iodice MW; Carroll KM; Housden JE; Hunter M; Sabban S; Artymiuk PJ; Helm BA Mol Immunol; 2010; 48(1-3):128-36. PubMed ID: 20947168 [TBL] [Abstract][Full Text] [Related]
9. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract. Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732 [TBL] [Abstract][Full Text] [Related]
10. Production of monoclonal antibodies specific for native equine IgE and their application to monitor total serum IgE responses in Icelandic and non-Icelandic horses with insect bite dermal hypersensitivity. Wilson AD; Harwood L; Torsteinsdottir S; Marti E Vet Immunol Immunopathol; 2006 Aug; 112(3-4):156-70. PubMed ID: 16574245 [TBL] [Abstract][Full Text] [Related]
11. The soluble isoform of human FcɛRI is an endogenous inhibitor of IgE-mediated mast cell responses. Moñino-Romero S; Erkert L; Schmidthaler K; Diesner SC; Sallis BF; Pennington L; Jardetzky T; Oettgen HC; Bohle B; Fiebiger E; Szépfalusi Z Allergy; 2019 Feb; 74(2):236-245. PubMed ID: 30030936 [TBL] [Abstract][Full Text] [Related]
13. Characterization of an early signaling defect following Fc epsilonRI activation in the canine mastocytoma cell line, C2. Hunter MJ; Iodice MW; Pathak AK; Street MA; Helm BA Mol Immunol; 2009 Mar; 46(6):1260-5. PubMed ID: 19135724 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites. Platzer B; Baker K; Vera MP; Singer K; Panduro M; Lexmond WS; Turner D; Vargas SO; Kinet JP; Maurer D; Baron RM; Blumberg RS; Fiebiger E Mucosal Immunol; 2015 May; 8(3):516-32. PubMed ID: 25227985 [TBL] [Abstract][Full Text] [Related]
15. The alpha-galactosyl derivatives of ganglioside GD(1b) are essential for the organization of lipid rafts in RBL-2H3 mast cells. Silveira e Souza AM; Mazucato VM; de Castro RO; Matioli F; Ciancaglini P; de Paiva Paulino T; Jamur MC; Oliver C Exp Cell Res; 2008 Aug; 314(13):2515-28. PubMed ID: 18585706 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to equine CD23 identify the low-affinity receptor for IgE on subpopulations of IgM+ and IgG1+ B-cells in horses. Wagner B; Hillegas JM; Babasyan S Vet Immunol Immunopathol; 2012 Apr; 146(2):125-34. PubMed ID: 22405681 [TBL] [Abstract][Full Text] [Related]
17. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model. Hsu CL; Shiung YY; Lin BL; Chang HY; Chang TW Int Immunopharmacol; 2010 Apr; 10(4):533-9. PubMed ID: 20139035 [TBL] [Abstract][Full Text] [Related]
18. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis. Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875 [TBL] [Abstract][Full Text] [Related]
19. Rat basophil leukaemia (RBL) cells sensitized with low affinity IgE respond to high valency antigen. Collins AM; Basil M; Nguyen K; Thelian D Clin Exp Allergy; 1996 Aug; 26(8):964-70. PubMed ID: 8877164 [TBL] [Abstract][Full Text] [Related]
20. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. Daëron M; Malbec O; Latour S; Arock M; Fridman WH J Clin Invest; 1995 Feb; 95(2):577-85. PubMed ID: 7860741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]